Celebrex (celecoxib), the first COX-2 selective NSAID to hit the market

Patients are asking about Celebrex (celecoxib), the first COX-2 selective NSAID to hit the market.

It'll be co-promoted by Searle and Pfizer.

Celebrex is approved for rheumatoid and osteoarthritis. It's as effective as other NSAIDs for joint pain and swelling.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote